Article info
PDFPaper
Limits to research risks
- Dr F G Miller, Ph.D., Department of Bioethics, Clinical Center, National Institutes of Health, Building 10, Room 1C118, Bethesda, Maryland 208921-156, USA; fmiller{at}nih.gov
Citation
Limits to research risks
Publication history
- Received May 20, 2008
- Revised February 9, 2009
- Accepted April 15, 2009
- First published June 30, 2009.
Online issue publication
April 27, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
2009 BMJ Publishing Group & Institute of Medical Ethics
Other content recommended for you
- Assessing research risks systematically: the net risks test
- Individual risk and community benefit in international research
- Risk, double effect and the social benefit requirement
- The potential benefit of the placebo effect in sham-controlled trials: implications for risk-benefit assessments and informed consent
- “Fair’s fair argument” and voluntarism in clinical research: But, is it fair?
- Can informed consent to research be adapted to risk?
- When to start paediatric testing of the adult HIV cure research agenda?
- The ethics of biosafety considerations in gain-of-function research resulting in the creation of potential pandemic pathogens
- Children in health research: a matter of trust
- Process of risk assessment by research ethics committees: foundations, shortcomings and open questions